DK0695177T3 - Plaster indeholdende aktivt stof - Google Patents

Plaster indeholdende aktivt stof

Info

Publication number
DK0695177T3
DK0695177T3 DK94913616T DK94913616T DK0695177T3 DK 0695177 T3 DK0695177 T3 DK 0695177T3 DK 94913616 T DK94913616 T DK 94913616T DK 94913616 T DK94913616 T DK 94913616T DK 0695177 T3 DK0695177 T3 DK 0695177T3
Authority
DK
Denmark
Prior art keywords
active substance
containing active
patch containing
vitamin
patch
Prior art date
Application number
DK94913616T
Other languages
English (en)
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK0695177T3 publication Critical patent/DK0695177T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DK94913616T 1993-04-20 1994-04-20 Plaster indeholdende aktivt stof DK0695177T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4312818 1993-04-20
DE19934339400 DE4339400A1 (de) 1993-11-18 1993-11-18 Wirkstoffpflaster
PCT/EP1994/001231 WO1994023707A1 (de) 1993-04-20 1994-04-20 Wirkstoffplaster

Publications (1)

Publication Number Publication Date
DK0695177T3 true DK0695177T3 (da) 1998-09-28

Family

ID=25925074

Family Applications (2)

Application Number Title Priority Date Filing Date
DK94913616T DK0695177T3 (da) 1993-04-20 1994-04-20 Plaster indeholdende aktivt stof
DK97113342T DK0813865T3 (da) 1993-04-20 1994-04-20 Plaster med virksomt stof

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97113342T DK0813865T3 (da) 1993-04-20 1994-04-20 Plaster med virksomt stof

Country Status (14)

Country Link
US (2) US5683711A (da)
EP (2) EP0695177B1 (da)
JP (1) JP3489831B2 (da)
AT (2) ATE205706T1 (da)
AU (1) AU678237B2 (da)
CA (1) CA2161004C (da)
DE (2) DE59405277D1 (da)
DK (2) DK0695177T3 (da)
ES (2) ES2115231T3 (da)
FI (1) FI114782B (da)
HU (2) HU223045B1 (da)
NO (1) NO311829B1 (da)
PT (1) PT813865E (da)
WO (1) WO1994023707A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
WO1996040085A2 (en) * 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19642043A1 (de) * 1995-10-23 1997-04-24 Hexal Ag Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
AU1800099A (en) 1997-11-25 1999-06-15 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
NZ512599A (en) 1998-12-30 2003-10-31 Dexcel Ltd Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) * 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en) * 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
WO2002054996A2 (en) * 2000-10-23 2002-07-18 Euro Celtique Sa Terazosin transdermal device and methods
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US20040258739A1 (en) * 2001-09-04 2004-12-23 Rudy Susilo Plaster for the treatment of dysfunctions and disorders of nails
CN101455649B (zh) * 2002-06-10 2014-02-26 欧洲凯尔特公司 防止所含活性剂被误用的经皮给药器的处置系统
JP2006517124A (ja) * 2003-02-07 2006-07-20 エルテーエス ローマン テラピー−ジステーメ アーゲー 活性物質の浸透を促進するために熱を用いるのに適した経皮治療システム及びその使用
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
ES2626784T3 (es) * 2003-10-28 2017-07-26 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
US20070018059A1 (en) * 2005-07-25 2007-01-25 Woodcock John E Apparatus for holding a container at an angle
DK2120896T3 (da) * 2007-01-11 2017-09-11 Drossapharm Ag Medicinsk virksomt plaster
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
DK2640389T3 (da) 2010-11-17 2015-03-09 Hexal Ag Transdermalt terapeutisk system omfattende buprenorphin
WO2014159798A1 (en) 2013-03-13 2014-10-02 Avery Dennison Corporation Improving adhesive properties

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711916A (nl) * 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (da) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
JP2875611B2 (ja) * 1990-08-29 1999-03-31 エーザイ株式会社 ケイ酸カルシウム含有外用剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
NZ244862A (en) * 1991-10-23 1995-07-26 Block Drug Co Use of vitamin e in topical pharmaceuticals to enhance penetration of the active agent
DE4237453C1 (da) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
PT813865E (pt) 2002-02-28
FI114782B (fi) 2004-12-31
DK0813865T3 (da) 2001-11-19
CA2161004A1 (en) 1994-10-27
JPH09501398A (ja) 1997-02-10
US5683711A (en) 1997-11-04
HU223045B1 (hu) 2004-03-01
NO311829B1 (no) 2002-02-04
DE59409873D1 (de) 2001-10-25
EP0813865A1 (de) 1997-12-29
NO954186D0 (no) 1995-10-19
DE59405277D1 (de) 1998-03-26
CA2161004C (en) 2004-10-26
ES2164286T3 (es) 2002-02-16
ES2115231T3 (es) 1998-06-16
HU223042B1 (hu) 2004-03-01
HUT73668A (en) 1996-09-30
HU9502994D0 (en) 1995-12-28
WO1994023707A1 (de) 1994-10-27
ATE205706T1 (de) 2001-10-15
HU0301253D0 (en) 2003-07-28
EP0813865B1 (de) 2001-09-19
AU6569694A (en) 1994-11-08
FI954989A (fi) 1995-10-19
US5830505A (en) 1998-11-03
EP0695177B1 (de) 1998-02-18
AU678237B2 (en) 1997-05-22
NO954186L (no) 1995-10-19
ATE163262T1 (de) 1998-03-15
EP0695177A1 (de) 1996-02-07
FI954989A0 (fi) 1995-10-19
JP3489831B2 (ja) 2004-01-26

Similar Documents

Publication Publication Date Title
DK0695177T3 (da) Plaster indeholdende aktivt stof
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
NO933854D0 (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
NO961963L (no) Mikrokapsler som inneholder suspensjoner av biologisk aktive forbindelser
ATE205730T1 (de) Antimikrobielle verbindungen enthaltende cyanoacrylat-zusammensetzungen
ES2103952T3 (es) Sistemas terapeuticos transdermicos.
ES2192245T3 (es) Emplastos que contienen principios activos.
DK0904063T3 (da) Fremgangsmåde til fremstilling af mikropartikler
DE69025187D1 (de) Ausstampfbare und spendbare etiketten
ZA915769B (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
PT806202E (pt) Composicao farmaceutica a base de matrizes lipofilas estabilizadas para a libertacao controlada de principios activos
ES2052528T3 (es) Un metodo para la fabricacion de una preparacion farmaceutica para absorcion percutanea.
DK0579939T3 (da) Phospholipidderivater
DE3773330D1 (de) Lichtempfindliches material mit silberhalogenid, reduktionsmittel und photopolymerisierbaren verbindungen.
DE3787580D1 (de) Lichtempfindliches material mit silberhalogenid, reduktionsmittel und photopolymerisierbare verbindungen.
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
ECSP951483A (es) Heteroaril--oxazolidinonas de 5 eslabones que contienen nitrogeno
FI921175A0 (fi) Biologiskt aktiv kemisk foerening.